KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Total Current Liabilities (2022 - 2025)

QuidelOrtho's Total Current Liabilities history spans 4 years, with the latest figure at $767.9 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities changed N/A year-over-year to $767.9 million; the TTM value through Sep 2025 reached $767.9 million, changed N/A, while the annual FY2024 figure was $998.8 million, N/A changed from the prior year.
  • Total Current Liabilities for Q3 2025 was $767.9 million at QuidelOrtho, down from $1.0 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.0 billion in Q1 2025 and bottomed at $323.5 million in Q1 2022.
  • The 4-year median for Total Current Liabilities is $932.4 million (2024), against an average of $853.8 million.
  • The largest YoY upside for Total Current Liabilities was 211.28% in 2023 against a maximum downside of 211.28% in 2023.
  • A 4-year view of Total Current Liabilities shows it stood at $900.0 million in 2022, then rose by 11.89% to $1.0 billion in 2023, then dropped by 0.81% to $998.8 million in 2024, then fell by 23.12% to $767.9 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Total Current Liabilities are $767.9 million (Q3 2025), $1.0 billion (Q1 2025), and $998.8 million (Q4 2024).